These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34096874)

  • 21. Automated Insulin Delivery in Real Life (AID-IRL): Real-World User Perspectives on Commercial AID.
    Lewis D
    J Diabetes Sci Technol; 2022 Mar; 16(2):500-503. PubMed ID: 32935554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Learning challenges of healthcare professionals supporting open-source automated insulin delivery.
    Crocket H; Lewis DM; Burnside M; Faherty A; Wheeler B; Frewen C; Lever C; Jefferies C; Williman J; Sanders O; Wilson R; Paul R; Price S; Jones S; de Bock M
    Diabet Med; 2022 May; 39(5):e14750. PubMed ID: 34826158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.
    Crabtree TSJ; Choudhary P; Lumb A; Hammond P; McLay A; Campbell F; Ng SM; Wilmot EG; Hussain S
    Diabetes Ther; 2022 Feb; 13(2):341-353. PubMed ID: 35099784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine.
    Burnside M; Crocket H; Mayo M; Pickering J; Tappe A; de Bock M
    J Diabetes Sci Technol; 2020 Sep; 14(5):878-882. PubMed ID: 31876179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.
    Fuchs J; Allen JM; Boughton CK; Wilinska ME; Thankamony A; de Beaufort C; Campbell F; Yong J; Froehlich-Reiterer E; Mader JK; Hofer SE; Kapellen TM; Rami-Merhar B; Tauschmann M; Hood K; Kimbell B; Lawton J; Roze S; Sibayan J; Cohen N; Hovorka R;
    BMJ Open; 2021 Feb; 11(2):e042790. PubMed ID: 33579766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System.
    Polonsky WH; Hood KK; Levy CJ; MacLeish SA; Hirsch IB; Brown SA; Bode BW; Carlson AL; Shah VN; Weinstock RS; Bhargava A; Jones TC; Aleppo G; Mehta SN; Laffel LM; Forlenza GP; Sherr JL; Huyett LM; Vienneau TE; Ly TT;
    Diabetes Res Clin Pract; 2022 Aug; 190():109998. PubMed ID: 35853530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System.
    Suttiratana SC; Wong JJ; Lanning MS; Dunlap A; Hanes SJ; Hood KK; Lal RA; Naranjo D
    Diabetes Technol Ther; 2022 Jun; 24(6):416-423. PubMed ID: 35099278
    [No Abstract]   [Full Text] [Related]  

  • 28. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health Care Provider Knowledge and Perceptions of FDA-Approved and Do-It-Yourself Automated Insulin Delivery.
    Murray JA; Clayton MF; Litchman ML
    J Diabetes Sci Technol; 2020 Nov; 14(6):1017-1021. PubMed ID: 31876176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 31. Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology.
    Pinsker JE; Müller L; Constantin A; Leas S; Manning M; McElwee Malloy M; Singh H; Habif S
    Diabetes Technol Ther; 2021 Feb; 23(2):120-127. PubMed ID: 32846114
    [No Abstract]   [Full Text] [Related]  

  • 32. Closed-loop insulin delivery in type 1 diabetes.
    Thabit H; Hovorka R
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):105-17. PubMed ID: 22575409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. User-driven open-source artificial pancreas systems and patient-reported outcomes: A missed opportunity?
    Vallis M; Holt RIG
    Diabet Med; 2022 May; 39(5):e14797. PubMed ID: 35092089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Do-It-Yourself Artificial Pancreas: A Comprehensive Review.
    Kesavadev J; Srinivasan S; Saboo B; Krishna B M; Krishnan G
    Diabetes Ther; 2020 Jun; 11(6):1217-1235. PubMed ID: 32356245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.
    Braune K; Lal RA; Petruželková L; Scheiner G; Winterdijk P; Schmidt S; Raimond L; Hood KK; Riddell MC; Skinner TC; Raile K; Hussain S;
    Lancet Diabetes Endocrinol; 2022 Jan; 10(1):58-74. PubMed ID: 34785000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.
    Jennings P; Hussain S
    J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
    Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
    Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
    [No Abstract]   [Full Text] [Related]  

  • 39. "Do It Yourself" (DIY)-Automated Insulin Delivery (AID) Systems: Current Status From a German Point of View.
    Heinemann L; Lange K
    J Diabetes Sci Technol; 2020 Nov; 14(6):1028-1034. PubMed ID: 31875681
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.